Clinical trials
Trials in Malta
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2005 | 2 |
| 2006 | 5 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 5 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 6 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
| Unknown status | 5 |
| Terminated | 2 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Approved for marketing | 1 |
| Enrolling by invitation | 1 |
| No longer available | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Malta | 9 |
| AstraZeneca | 4 |
| Sciberras, Stephen M.D. | 4 |
| Eli Lilly and Company | 2 |
| Mater Dei Hospital, Malta | 2 |
| Novartis Pharmaceuticals | 2 |
| Pfizer | 2 |
| Puma Biotechnology, Inc. | 2 |
| Queen Mary University of London | 2 |
| Abbott Medical Devices | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 8 |
| Heart Failure | 5 |
| COVID-19 | 3 |
| Neoplasm Metastasis | 3 |
| Anxiety Disorders | 2 |
| Arthritis, Rheumatoid | 2 |
| Coronary Artery Disease | 2 |
| Diabetes Mellitus | 2 |
| Heart Defects, Congenital | 2 |
| Hypertension | 2 |
Trials
Showing 51 to 57 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.